Get started
TRULIEVE CANNABIS CORP.TT

TRULIEVE CANNABIS CORP.

No trades
See on Supercharts
Overview Financials News
Ideas
Discussions Technicals Forecast Seasonals Bonds

TRUL trade ideas

$TCNNF is Technically Leading the Green WaveTCNNF Shares of the stock have been a powerhouse leader in the cannabis patch in recent action. This is one of a very, very select group that has shown genuine technical strength not simply tied to US legislative moves. The stock is on a roll and still has a ways to go before flashing worrisome levels of overbought-ness. Trulieve Cannabis Corp (OTCMKTS:TCNNF) just announced its financial results for the third quarter of 2019 ended September 30, 2019, including record revenue of $70.7 million, an increase of 22% on a sequential quarter-to-quarter basis, and an adjusted EBITDA increase from $31.6 million in Q2 2019 to $36.9 million at September 30, 2019. "Our third quarter results reflect our continued customer loyalty, growth, and leadership position. Trulieve's strong brand, wide-ranging access to stores, and authentic customer experience have resonated with our customers and patients," stated Kim Rivers, Trulieve CEO. "The third quarter was also successful in further strengthening our position in our existing markets as well as preparing for new market entry. We continue to build operational efficiencies and financial discipline to ensure a solid foundation, cash reserves, and the right tools at our disposal to expand our footprint. Looking ahead, this is an exciting time as we execute on our strategic vision to be one of the top performing cannabis companies in North America." Trulieve Cannabis Corp (OTCMKTS:TCNNF) promulgates itself as a company that, through its subsidiary, Trulieve, Inc., engages in the cultivation, possession, distribution, and sale of medical cannabis in the United States. It offers a suite of Trulieve branded products with approximately 125 SKUs, including nasal sprays, capsules, concentrates, syringes, and cannabis flower in tamper-proof containers for vaporizers, topical creams, tinctures, and vape cartridges. Read More at: dailytrendingstocks.com
OTC:TCNNF
by GregFolin
TRULIEVE - Bullish or Bearish ?Dear Traders, A little update on TRULIEVE. Price retraced towards the 0.5 fib level and touched it many times, but the bulls managed to close with the price above the fib level, and above the 55 ema, which is a bullish sign, but on the other hand I see a MACD that isn't crossing upwards yet, and a RSI that's under 50. These indicators show many a lot of possibilities so I prefer to stay Neutral until further notice. What are your thoughts ?
O
by Raw_Blitz
16
SENTIMENT change in Truleive Cannabis.P/E RATIO WELL VALUED AMONG ITS PEERS ANALYSTS AVERAGE PRICE TARGET $20 COMPANY PROFILE Trulieve Cannabis Corp. engages in the provision of medical cannabis products. The firm cultivates and produces its products in-house and distributes to its branded stores, as well as directly to patients via home delivery. Its products include smokable flower, inhalation, oral, sublingual, topical, inter-nasal, and concentrates. The company was founded on September 21, 2018 and is headquartered in Quincy, FL.
OLong
by OTCMarketsExpert
Trulieve Cannabis Corp After doing some research on this company, I would give it a chance. We have hit bottom and bounced nicely. So I will expect two things... 1. We just continue up with no pullback to around Jan 15 - 17 high of earlier this year. Minor correction or consolidation zone around 10 that could breakout and has the probability to make a run for it to 15 or higher. Production of hemp and cannabis went up about 500% in the U.S. back in 2016..since then its been spend spend spend to develop the industry in america and make it profitable. I actually am focusing on these companies in my recruitment business and what better way than to support them via stocks as well? Ill buy at these levels :) Low risk higher reward.
OLong
by AschraM
Trulieve a risky LONG into earnings The best part of the story is that Trulieve has entered into three additional state markets. The company has an avenue for growth beyond Florida with a store in both California and Connecticut and plans to enter Massachusetts. The stock has a market cap of $1.2 billion and a reasonable path to achieve the 2020 EBITDA target of $150 million. A normal stock generating 50% EBITDA growth over the ~$100 million target in 2019 would normally trade at substantially higher multiples than 8x estimates. Even a doubling of the stock wouldn’t bring the valuation multiple above the norms for 50% EBITDA growth. In addition, the EBITDA margin is expected to dip initially as Trulieve looks to expand beyond the well-established Florida market. The company forecasts a 500-basis point hit to margins in 2020 from the peak level at 43.5% in 2019. For Q1 reported at the end of May, Trulieve reported impressive 192% revenue growth. The company reached quarterly revenues of $44.5 million and more importantly produced a positive adjusted EBITDA of $19.0 million. The multi-state operator (MSO) hasn’t made aggressive acquisitions or wild moves into other states leaving a focus on Florida to generate solid margins. Trulieve recently opened the 30th dispensary in the state. With a focus on Florida, Trulieve achieved Q1 gross margins of 67%. The ability to control operating expenses by not having wild expansion plans into 10 to 15 states has allowed for limited operating expenses of $11.9 million. The company only spends about 27% of revenue on operating expenses which opens up the door for large profits in a growth mode. SOURCE Smarter analysis AVERAGE ANALYSTS PRICE TARGET $30 AVERAGE ANALYSTS RECOMMENDATION BUY P/E RATIO 20 COMPANY PROFILE Trulieve Cannabis Corp. engages in the provision of medical cannabis products. The firm cultivates and produces its products in-house and distributes to its branded stores, as well as directly to patients via home delivery. Its products include smokable flower, inhalation, oral, sublingual, topical, inter-nasal, and concentrates. The company was founded on September 21, 2018 and is headquartered in Quincy, FL.
OLong
by OTCMarketsExpert
1
Cup and handle Seems like a great setup for a possible cup and handle style breakout. Lots of space for a healthy pullback while still maintaining the 12 and 26 day EMAs as support before trying to break the double top at 16.70. If that breaks with heavy volume, I don't see why it couldn't take out the next resistance at 17.50 before heading up. The broader stock market is getting pretty frothy right now though, so this may take some time to play out as the bulls take a little breather.
CLong
by tradingzebras
Trulieve - Bears are in controlDear Traders, Trulieve enjoyed a small 4% run after it broke out of the triangle, after this a lot of selling pressure occurred, as this stock is quite new on the market, we can't tell much yet. For example, there is still no 55 ema showing, no 100 ema and also no 200ema. Once these indicators will show up we will be abel to tell more about trulieve price action and most importantly, trulieve's future! Any thoughts? Feel free to join my new Discord Channel if you interested in talking to me and others about stocks, info and of course opportunities! discord.gg Thanks !
OShort
by Raw_Blitz